Human skin Langerhans cells are targets of dengue virus infection

Nature Medicine

Volumn 6, Issue 7, 2000, Pages 816-820

  Wu, Shuenn Jue L ^a,b   Grouard Vogel, Geraldine ^c   Sun, Wellington ^d   Mascola, John R ^c   Brachtel, Elena ^c,e   Putvatana, Ravithat ^a   Louder, Mark K ^c   Filgueira, Luis ^f   Marovich, Mary A ^c   Wong, Henry K ^g   Blauvelt, Andrew ^h   Murphy, Gerald S ^a,b   Robb, Merlin L ^c   Innes, Bruce L ^d,i   Birx, Deborah L ^c   Hayes, Curtis G ^a   Frankel, Sarah Schlesinger ^c,e  

^a NAVAL MEDICAL RESEARCH CENTER   (United States)

^b Uniformed Services University of the Health Sciences and the Walter Reed National Military Medical Center   (United States)

^c HENRY M JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE   (United States)

^d WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

^e ARMED FORCES INSTITUTE OF PATHOLOGY   (United States)

^f UNIVERSITY OF ZURICH   (Switzerland)

^g Dept Dermatol Walter Reed Army M ^*  (United States)

^h NATIONAL CANCER INSTITUTE   (United States)

ⁱ GLAXOSMITHKLINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; DENGUE; DENGUE VIRUS; HUMAN; HUMAN CELL; LANGERHANS CELL; PATHOGENESIS; PRIORITY JOURNAL; TARGET CELL; VIRUS TRANSMISSION;

BLOOD CELLS; DENGUE VIRUS; DERMIS; EXANTHEMA; HUMANS; LANGERHANS CELLS; MACROPHAGES; MONOCYTES; SKIN; VIRAL PROTEINS; VIRAL VACCINES;

ARTHROPODA; DENGUE VIRUS; FLAVIVIRUS; RNA VIRUSES;

EID: 0033914368     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/77553     Document Type: Article

References (21)

1. Halstead, S.B. Pathogenesis of dengue: challenges to molecular biology. Science 239, 476-481 (1988).
2. Rigau-Perez, J. et al. Dengue and dengue heamorrhagic fever. Lancet 352, 971-977 (1998).
3. Taweechaisupapong, S. et al. Langerhans cell density and serological changes following intradermal immunisation of mice with dengue 2 virus. J. Med. Microbiol. 45, 138-145 (1996).
4. Taweechaisupapong, S., Sriurairatana, S., Angsubhakorn, S., Yoksan, S. & Bhamarapravati, N. In vivo and in vitro studies of the morphological change in the monkey epidermal Langerhans cells following exposure to dengue 2 virus. Southeast Asian J. Trop. Med. Public Health 27, 664-672 (1996).
5. Cella, M. et al. Maturation, activation, and protection of dendritic cells induced by double-stranded RNA. J. Exp. Med. 189, 821-829 (1999).
6. Rice, C.M. in Fields Virology (eds. Fields, B.N., Knipe, D.M. & Howley, P.M.) 931-959 (Lippincott-Raven, Philadelphia, 1996).
7. Pope, M., Betjes, M.G.H., Hirmand, H., Hoffman, L. & Steinman, R. Both dendritic cells and memory T lymphocytes emigrate from organ cultures of human skin and form distinctive dendritic-T-cell conjugates. J. Invest. Dermatol. 104, 11-17 (1995).
8. Labuda, M. et al. Importance of localized skin infection in tick-borne encephalitis virus transmission. Virology 219, 357-366 (1996).
9. O'Sullivan, M.K.H. The differentiation state of monocytic cells affects their susceptibility to infection and the effects of infection by dengue virus, J. Gen. Virol. 75, 2387-2392 (1994).
10. Morens, D. M., Halstead, S.B. & Marchette, N.J. Profiles of antibody-dependent enhancement of dengue virus type 2 infection. Microb. Pathog. 3, 231-237 (1987).
11. Morens, D.M., Larsen, L.K. & Halstead, S.B. Study of the distribution of antibody-dependent enhancement determinants on dengue 2 isolates using dengue 2-derived monoclonal antibodies. J. Med. Virol. 22, 163-167 (1987).
12. Chen, Y. et al. Dengue virus infectivity depends on envelope protein binding to target cell heparin sulfate. Nature Med. 3, 866-871 (1997).
13. Halstead, S., O'Rourke, E. & Allison, A. Dengue viruses and mononuclear phagocytes. J. Exp. Med. 146, 218-229 (1977).
14. Frankel, S.S. et al. Neutralizing monoclonal antibodies block human immunodeficiency virus type 1 infection of dendritic cells and transmission to T cells. J. Virol. 72, 9788-9794 (1998).
15. Pope, M. et al. Human immunodeficiency virus type 1 strains of subtypes B and E replicate in cutaneous dendritic cell T-cell mixtures without displaying subtype-specific tropism. J. Virol. 71, 8001-8007 (1997).
16. Henchal, E.A., McCown, J.M., Burke, D.S., Seguin, M.C. & Brandt, W.E. Epitopic analysis of antigenic determinants on the surface of dengue-2 virions using monoclonal antibodies. Am. J. Trop. Med. Hyg. 34, 162-169 (1985).
17. Raviprakash, K., Sinha, M., Hayes, C.G. & Porter, K.R. Conversion of dengue virus replication form RNA (RF) to replicative intermediate (RI) by nonstructural proteins NS-5 and NS-3. Am. J. Trop. Med. Hyg. 58, 90-95 (1998).
18. Morens, DM. Simplified plaque reduction neutralization assay for dengue viruses by semimicro methods in BHK-21 cells: Comparison of the BHK suspension test with standard plaque reduction neutralization. J. Clin. Microbiol. 22, 250-253 (1985).
19. Wu, S.-J.L. et al. Evaluation of the severe combined immunodeficient (SCID) mouse as an animal model for dengue viral infection. Am. J. Trop. Med. Hyg. 52, 468-476 (1995).
20. Frankel, S.S. et al. Active replication of HIV-1 at the lymphoepithelial surface of the tonsil. Am. J. Pathol. 151, 89-96 (1997).
21. de Saint-Vis, B. et al. A novel lysosome-associated membrane glycoprotein, DC-LAMP, induced upon DC maturation, is transiently expressed in MHC class II compartment. Immunity 9, 325-336 (1998).